Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;22(4):263-71.
doi: 10.1293/tox.22.263. Epub 2009 Dec 21.

Cyclooxygenase 2 and Prostaglandin E2 are not Involved in N-Nitrosodiethylamine-Initiated Early Rat Hepatocarcinogenesis

Cyclooxygenase 2 and Prostaglandin E2 are not Involved in N-Nitrosodiethylamine-Initiated Early Rat Hepatocarcinogenesis

Mahmoud M Said et al. J Toxicol Pathol. 2009 Dec.

Abstract

The present study was undertaken to investigate the effect of dietary supplementation with nimesulide or eugenol on N-nitrosodiethylamine (DEN)-initiated early hepatocarcinogenesis in F344 male rats. Both compounds did not alter the expression of cytochrome P450 (CYP) 2E1, the enzyme that plays a major role in the activation of DEN to genotoxic products; however, nimesulide induced the expression of CYP1A1. Western blot analysis revealed that COX-1 and COX-2 protein expressions were not modulated by DEN compared with normal controls. Furthermore, post-initiation feeding with nimesulide or eugenol did not modulate COX-2 protein expression in normal or DEN-treated rats, whereas eugenol significantly increased the liver prostaglandin E(2) (PGE(2)) levels of DEN-injected animals compared with the DEN controls. Ultimately, nimesulide or eugenol did not modify DEN-induced hepatocarcinogenesis as evidenced by insignificant changes in the number and size of preneoplastic placental glutathione S-transferase (GST-P) positive liver foci compared with the DEN controls. These results suggest that COX-2, as well as prostaglandin E(2), may play no role in the post-initiation development of DEN-induced rat hepatocarcinogenesis at an early stage.

Keywords: cyclooxygenases; eugenol; liver; nimesulide; rat.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Experimental protocol. A total of 42 six-week-old F344 male rats were used throughout this study. A group of thirty-three rats (each animal was injected with DEN) and a group of nine rats (each rat was injected with saline) were further subdivided each into three equally-sized groups as shown. The rats were sequentially sacrificed two or four weeks following DEN injection or 4 weeks following saline injection. formula image: Diethylnitrosamine (DEN), 200 mg/Kg b.w., i.p. formula image: Saline, i.p. formula image: Nimesulide 400 ppm in diet, formula image: Eugenol 6000 ppm in diet, formula image: Basal diet. S: Sacrifice.
Fig. 2
Fig. 2
A representative western blot showing the expression of cytochrome P450 (CYP) 1A1/1A2 and 2E1 proteins in the livers of F344 male rats two weeks after DEN injection and treatment with nimesulide (NIM) or eugenol (EUG). The histogram shows the relative densities of bands normalized to β-actin (means ± SE). * Significantly different from the DEN controls at P<0.05 by LSD test.
Fig. 3
Fig. 3
A representative western blot showing the expression of cyclooxygenase (COX)-1 and COX-2 proteins in the livers of F344 male rats four weeks following DEN injection and treatment with nimesulide (NIM) or eugenol (EUG). The histogram shows the relative densities of bands normalized to β-actin (means ± SE).
Fig. 4
Fig. 4
A representative western blot showing the expression of COX-1 and COX-2 proteins in the livers of normal F344 males, livers of those treated with nimesulide or eugenol and livers of DEN-injected rats. The histogram shows the relative densities of bands normalized to β-actin (means ± SE).
Fig. 5
Fig. 5
Representative hematoxylin and eosin staining (A, C, E, G, I and K) and immunohistochemical findings of GST-P positive liver preneoplastic foci (B, D, F, H, J and L) of the DEN controls two weeks (A and B) and four weeks (C and D) after DEN injection (200 mg/Kg b.w.) and following treatment with nimesulide (E and F, G and H) or eugenol ( I and J, K and L) for one or three weeks , respectively (×20). Arrows indicate foci.
Fig. 6
Fig. 6
Statistical comparison of the number of GST-P positive liver cell foci (No./cm2) in F344 male rats two and four weeks after DEN injection and treatment with nimesulide (NIM) or eugenol (EUG), as compared with their counterpart DEN controls (values are means ± SE).
Fig. 7
Fig. 7
Statistical comparison of the areas of GST-P positive liver cell foci (mm2/cm2) in F344 male rats two and four weeks following DEN injection and treatment with nimesulide (NIM) or eugenol (EUG), as compared with their counterpart DEN controls (values are means ± SE).

References

    1. Sakata K, Hara A, Hirose Y, Yamada Y, Kuno T, Katayama M, Yoshida K, Zheng Q, Murakami A, Ohigashi H, Ikemoto K, Koshimizu K, Tanaka T, Mori H. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis. Oncology. 2004;66:244–252. - PubMed
    1. Motola-Kuba D, Zamora-Valdés D, Uribe M, Méndez-Sánchez N. Hepatocellular carcinoma. An overview. Ann Hepatol. 2006;5:16–24. - PubMed
    1. Fahim FA, Chipman JK. Illustration of the antioxidant and/or antimutagenic effect of eugenol on HepG2 cells treated with AF-B1 using single cell gel electrophoresis (comet assay) and electron microscopy (E.M.) Cell Mol Biol. 2001;8:1599–1611.
    1. Yamazaki H, Oda Y, Funae Y, Imaoka S, Inui Y, Guengerich FP, Shimada T. Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethyl-amine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurim strain (NM2009) Carcinogenesis. 1992;13:979–985. - PubMed
    1. Ramakrishnan G, Elinos-Báez CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T. Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma. Mol Cell Biochem. 2008;313:53–61. - PubMed